Where is Doctronic headquartered?

Doctronic is headquartered in New York, USA. The company has a team of 101-500 people.

What does Doctronic do?

Doctronic operates in the AI in Healthcare sector. An AI-powered healthcare platform for personalized medical assessments, symptom checking, and connecting patients with licensed doctors. To provide fast, free, and personalized AI-driven medical guidance as a trustworthy alternative to online search engines, with a seamless and affordable option for video consultations with licensed doctors.

When was Doctronic founded?

Doctronic was founded in 2023. It is based in New York, USA.

Who is the CEO of Doctronic?

Matt Pavelle is the CEO of Doctronic. The company was founded in 2023.

Where is Doctronic located?

Doctronic is headquartered in New York, USA.

What funding stage is Doctronic at?

Doctronic is currently at the Growth Stage stage.

How many employees does Doctronic have?

Doctronic has approximately 101-500 employees.

Doctronic

Category: AI in Healthcare

An AI-powered healthcare platform for personalized medical assessments, symptom checking, and connecting patients with licensed doctors. Doctronic was founded in 2023. The company is led by Matt Pavelle. Based in New York, USA. Team size: 101-500. Total funding raised: $65M. Latest round: Series B. Key investors include Union Square Ventures, Lightspeed Venture Partners, Abstract, Tusk Ventures, Mantis VC, Seven Stars, Wittington Ventures, ARTIS.

Founded: 2023
Headquarters: New York, USA
Team size: 101-500
Total funding: $65M

Value proposition

To provide fast, free, and personalized AI-driven medical guidance as a trustworthy alternative to online search engines, with a seamless and affordable option for video consultations with licensed doctors.

Products and solutions

AI-powered health assistant for symptom checking and medical information, Telehealth platform for video visits with licensed doctors, Pediatric primary care expansion through acquisition of Summer Health, a virtual text-based pediatric care platform (July 29, 2026)

Unique value

Doctronic's core innovation is its use of AI agents for primary care triage, aiming to replace unreliable online self-diagnosis. It provides a trusted, interactive, and personalized healthcare experience that acts as a collaborative tool between the AI and human doctors.

Target customer

Individual consumers and patients seeking immediate, reliable medical information and affordable consultations.

Industries served

Healthcare, Digital Health, Telemedicine

Technology advantage

The company's main advantage is its scalable, AI-driven platform that offers initial medical consultations for free. This model efficiently funnels users who require further care to its integrated network of human doctors for a low-cost fee, creating an accessible and efficient healthcare solution.

How they differentiate

Doctronic differentiates itself by being an 'AI-first' platform that maintains a continuous care relationship, remembering a user's entire health history. Unlike telehealth services that primarily connect patients to human doctors, Doctronic provides an initial comprehensive assessment and ongoing guidance through its advanced AI, positioning itself as a superior alternative to searching for symptoms online ('Dr. Google').

Main competitors

Ro, Amwell, K Health

Key partnerships

Union Square Ventures (Investor), Tusk Ventures (Investor), HF0 (Startup Accelerator/Investor), Utah Department of Commerce / Office of AI Policy (AI Prescription Renewal Partnership), Abstract (Investor), Lightspeed Venture Partners (Investor), Simple HealthKit (At-home screening integrated with AI assessment and clinical follow-up; announced June 29, 2026)

Notable customers

Reportedly assisted in diagnosing a user's mystery illness, which was highlighted in a Fox Business interview.

Major milestones

Raised a $5M seed round led by Union Square Ventures., Secured a $20M Series A round., Surpassed 10 million AI-powered medical consultations., Became first AI legally authorized to renew prescriptions in the U.S. via Utah partnership (Dec 2025/Jan 2026)., Raised $40M Series B co-led by Abstract and Lightspeed Venture Partners (March 2026)., Surpassed 27 million AI-doctor visits., On track to earn $10M+ revenue in 2026., Acquired Summer Health and announced expansion into pediatric primary care on July 29, 2026; acquisition terms undisclosed.

Growth metrics

Reported more than 30 million health encounters as of July 29, 2026. Separately reported more than 300,000 unique weekly users on June 29, 2026.

Market positioning

Doctronic is positioned as a primary care triage tool, aiming to be the first point of contact for users' health concerns. They market themselves as 'the world's most popular AI doctor,' focusing on providing accessible, personalized, and immediate health information.

Geographic focus

Based in New York, USA, Doctronic primarily focuses on the United States market.

Patents and IP

Information not publicly available.

About Matt Pavelle

Serial entrepreneur and Carnegie Mellon University computer science graduate. Previously Co-Founder & CTO of Pinata and Founding CTO of Moda Operandi.

More AI in Healthcare companies

Official website: https://www.doctronic.ai/